Profiles

Keywords
Last Name
Institution

John Segreti

Concepts (235)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Anti-Bacterial Agents
25
2020
401
4.050
Why?
Daptomycin
9
2013
17
2.110
Why?
Staphylococcal Infections
6
2018
165
1.630
Why?
Prosthesis-Related Infections
7
2020
204
1.440
Why?
Anti-Infective Agents
10
2005
56
1.190
Why?
Gram-Positive Bacterial Infections
5
2013
63
1.130
Why?
Bacterial Infections
5
2011
70
1.090
Why?
Staphylococcus aureus
7
2018
81
0.990
Why?
Infection Control
3
2018
166
0.930
Why?
Catheterization, Central Venous
2
2011
44
0.830
Why?
Fluoroquinolones
7
2011
24
0.790
Why?
Skin Diseases, Bacterial
3
2018
6
0.790
Why?
Surgical Wound Infection
2
2017
102
0.770
Why?
Bacteria
4
2011
67
0.760
Why?
Soft Tissue Infections
3
2018
25
0.760
Why?
Sepsis
3
2011
153
0.750
Why?
Bacteremia
2
2010
122
0.710
Why?
Enterococcus
4
2013
62
0.690
Why?
Methicillin-Resistant Staphylococcus aureus
2
2016
101
0.690
Why?
Arthroplasty, Replacement
1
2017
143
0.610
Why?
Humans
50
2020
29841
0.570
Why?
Endocarditis, Bacterial
2
2006
16
0.550
Why?
Acetamides
2
2010
8
0.540
Why?
Microbial Sensitivity Tests
12
2018
111
0.540
Why?
Oxazolidinones
2
2010
8
0.540
Why?
Vancomycin Resistance
2
2010
31
0.530
Why?
Quinolones
5
1991
23
0.470
Why?
Methicillin Resistance
2
2008
33
0.460
Why?
Antibiotic Prophylaxis
3
2016
35
0.410
Why?
Cross Infection
4
2018
291
0.390
Why?
Diagnostic Tests, Routine
2
2019
16
0.390
Why?
Catheters, Indwelling
1
2008
29
0.380
Why?
Hospitals, University
1
2008
45
0.380
Why?
Benchmarking
1
2008
28
0.380
Why?
Pneumonia, Bacterial
2
2005
15
0.370
Why?
Attitude of Health Personnel
1
2009
177
0.360
Why?
Quality of Health Care
2
2011
134
0.360
Why?
Cefazolin
2
2018
6
0.360
Why?
Chlamydia trachomatis
4
1991
16
0.350
Why?
Gram-Negative Bacterial Infections
2
2007
26
0.350
Why?
Health Knowledge, Attitudes, Practice
1
2009
223
0.340
Why?
Bone Diseases
1
2005
24
0.320
Why?
Microbiological Techniques
2
2016
10
0.320
Why?
Arthroplasty, Replacement, Knee
3
2020
646
0.310
Why?
Critical Care
1
2008
220
0.310
Why?
United States
6
2017
2402
0.300
Why?
Arthroplasty, Replacement, Hip
3
2020
819
0.300
Why?
Ambulatory Care
1
2005
86
0.300
Why?
Infection Control Practitioners
1
2004
2
0.300
Why?
Equipment Contamination
1
2004
28
0.290
Why?
Joint Diseases
1
2005
114
0.290
Why?
Ambulatory Care Facilities
1
2004
39
0.280
Why?
Knee Prosthesis
2
2020
233
0.270
Why?
Retrospective Studies
10
2018
3303
0.260
Why?
Treatment Outcome
10
2015
3788
0.240
Why?
Cephalosporins
3
1997
18
0.230
Why?
Hip Prosthesis
3
2020
554
0.230
Why?
Disease Management
2
2019
149
0.220
Why?
Orthopedic Fixation Devices
1
1999
24
0.220
Why?
Discitis
1
2019
3
0.210
Why?
Heart Valve Prosthesis
1
1999
40
0.210
Why?
Surgical Procedures, Operative
1
2019
38
0.210
Why?
Adult
13
2018
9591
0.210
Why?
Drug Resistance, Bacterial
2
2011
53
0.200
Why?
Genes, Bacterial
1
2018
8
0.200
Why?
Fasciitis, Necrotizing
1
2018
2
0.190
Why?
Male
17
2020
17153
0.190
Why?
Carrier State
1
2018
52
0.190
Why?
Enterobacteriaceae Infections
1
2018
48
0.190
Why?
Meningitis, Bacterial
1
1996
9
0.180
Why?
Reoperation
2
2020
911
0.180
Why?
Middle Aged
12
2020
11053
0.170
Why?
Legionella pneumophila
1
1996
1
0.170
Why?
Clarithromycin
1
1996
7
0.170
Why?
Azithromycin
1
1996
3
0.170
Why?
Erythromycin
1
1996
11
0.170
Why?
Mass Screening
1
2018
193
0.170
Why?
Aged
10
2020
9833
0.170
Why?
Prosthesis Failure
1
2020
520
0.160
Why?
Oxacillin
1
2015
3
0.160
Why?
Methicillin
1
2015
4
0.160
Why?
Arthroplasty
1
2016
124
0.160
Why?
Drug Hypersensitivity
1
1995
19
0.160
Why?
Sexually Transmitted Diseases, Bacterial
2
1991
3
0.160
Why?
Diarrhea
3
1990
54
0.160
Why?
Ceftizoxime
1
1994
2
0.150
Why?
Chicago
4
2018
916
0.150
Why?
Female
13
2020
17657
0.150
Why?
Aged, 80 and over
6
2018
5016
0.150
Why?
Neisseria gonorrhoeae
2
1991
7
0.140
Why?
Cyclic N-Oxides
1
1993
5
0.140
Why?
Campylobacter
1
1993
8
0.140
Why?
Quinoxalines
1
1993
10
0.140
Why?
Enterococcus faecalis
1
2013
8
0.140
Why?
Clostridium difficile
1
1993
19
0.140
Why?
Endocarditis
1
2013
16
0.140
Why?
Enterococcus faecium
1
2013
16
0.140
Why?
Drainage
1
2013
54
0.140
Why?
Uterine Cervicitis
1
1991
2
0.130
Why?
Urethritis
1
1991
2
0.130
Why?
Aza Compounds
1
2011
1
0.120
Why?
Administration, Ophthalmic
1
2011
1
0.120
Why?
Azepines
1
2011
7
0.120
Why?
Quinolines
1
2011
19
0.120
Why?
Cohort Studies
3
2015
1911
0.120
Why?
4-Quinolones
4
1995
6
0.120
Why?
Serratia marcescens
1
2010
11
0.120
Why?
Serratia Infections
1
2010
10
0.120
Why?
Naphthyridines
1
1990
3
0.110
Why?
Risk Reduction Behavior
1
2011
55
0.110
Why?
Cost-Benefit Analysis
1
2011
144
0.110
Why?
Data Interpretation, Statistical
1
2010
96
0.110
Why?
Health Care Costs
1
2011
79
0.110
Why?
Disease Outbreaks
1
2010
88
0.110
Why?
Illinois
1
2011
265
0.110
Why?
Tetracyclines
1
1989
3
0.110
Why?
Rifampin
1
1989
7
0.100
Why?
Minocycline
1
1989
8
0.100
Why?
Drug Resistance, Microbial
3
1996
96
0.100
Why?
Multivariate Analysis
1
2010
390
0.100
Why?
Models, Biological
1
2011
422
0.100
Why?
Shock, Septic
1
1989
64
0.100
Why?
Vancomycin
1
2008
53
0.090
Why?
Acquired Immunodeficiency Syndrome
1
1988
100
0.090
Why?
Product Surveillance, Postmarketing
1
2007
19
0.090
Why?
Skin Diseases, Infectious
1
2007
9
0.090
Why?
Algorithms
1
2010
414
0.090
Why?
Quality Indicators, Health Care
1
2008
44
0.090
Why?
Guideline Adherence
1
2008
81
0.090
Why?
Time Factors
4
2020
1894
0.090
Why?
Q Fever
1
2006
5
0.090
Why?
Travel
1
2006
15
0.090
Why?
Community-Acquired Infections
2
2005
74
0.090
Why?
Prognosis
1
2010
1025
0.090
Why?
Registries
1
2007
195
0.080
Why?
Acute Disease
2
1997
272
0.080
Why?
Tobramycin
1
2005
11
0.080
Why?
Calcium Sulfate
1
2005
29
0.080
Why?
Bone Substitutes
1
2005
34
0.080
Why?
Dose-Response Relationship, Drug
3
2011
524
0.080
Why?
Humerus
1
2005
106
0.070
Why?
Joint Commission on Accreditation of Healthcare Organizations
1
2004
7
0.070
Why?
Doxycycline
3
2006
23
0.070
Why?
Animals
2
2011
5125
0.070
Why?
Risk Factors
1
2011
2549
0.070
Why?
Bone Transplantation
1
2005
229
0.070
Why?
Administration, Oral
2
2020
164
0.060
Why?
Practice Guidelines as Topic
1
2005
382
0.060
Why?
Ciprofloxacin
3
1993
28
0.060
Why?
Gram-Negative Bacteria
2
2007
37
0.060
Why?
Diagnosis, Differential
2
2006
466
0.060
Why?
Ofloxacin
2
1997
5
0.060
Why?
Macrolides
2
1997
7
0.050
Why?
Follow-Up Studies
3
2005
2017
0.050
Why?
Bacterial Load
1
2018
13
0.050
Why?
Gas Gangrene
1
2018
1
0.050
Why?
Leukocidins
1
2018
2
0.050
Why?
Exotoxins
1
2018
12
0.050
Why?
Pyomyositis
1
2018
5
0.050
Why?
Substance Abuse, Intravenous
1
2018
12
0.050
Why?
Rectum
1
2018
69
0.050
Why?
Dermatomycoses
1
2018
4
0.050
Why?
Administration, Intravenous
1
2018
35
0.050
Why?
Immunoglobulins
1
2018
33
0.050
Why?
Bacterial Toxins
1
2018
22
0.050
Why?
Tertiary Care Centers
1
2018
83
0.050
Why?
Prodrugs
1
1997
5
0.050
Why?
Cefuroxime
1
1997
2
0.050
Why?
Levofloxacin
1
1997
5
0.050
Why?
Ceftriaxone
1
1997
6
0.050
Why?
Immunocompromised Host
1
2018
51
0.050
Why?
Chronic Disease
1
2020
530
0.050
Why?
Bronchitis
1
1997
2
0.050
Why?
Otitis Media
1
1997
5
0.050
Why?
Pharyngitis
1
1997
6
0.040
Why?
Academic Medical Centers
1
2018
156
0.040
Why?
Streptococcal Infections
1
1997
18
0.040
Why?
Legionnaires' Disease
1
1996
1
0.040
Why?
Emergencies
1
1996
42
0.040
Why?
Bacteriological Techniques
1
1996
20
0.040
Why?
Prevalence
1
2018
533
0.040
Why?
Campylobacter Infections
2
1993
11
0.040
Why?
Intensive Care Units
1
2018
290
0.040
Why?
Listeriosis
1
1995
6
0.040
Why?
Skin Tests
1
1995
18
0.040
Why?
Staphylococcus
1
1995
11
0.040
Why?
Drug Utilization
1
1995
27
0.040
Why?
Arthritis, Infectious
1
1995
50
0.040
Why?
Adolescent
2
2018
2591
0.040
Why?
Sinusitis
1
1997
178
0.040
Why?
Campylobacter coli
1
1993
2
0.040
Why?
Metronidazole
1
1993
9
0.040
Why?
Borrelia burgdorferi Group
1
1993
6
0.040
Why?
Enterocolitis, Pseudomembranous
1
1993
16
0.030
Why?
Blood
1
2013
28
0.030
Why?
Creatine Kinase
1
2013
37
0.030
Why?
Drug Administration Schedule
1
2013
265
0.030
Why?
Survival Analysis
1
2013
390
0.030
Why?
Osteoarthritis, Hip
1
2013
95
0.030
Why?
Ureaplasma urealyticum
1
1991
1
0.030
Why?
Mycoplasma
1
1991
4
0.030
Why?
Treponema pallidum
1
1991
4
0.030
Why?
Gonorrhea
1
1991
8
0.030
Why?
Prospective Studies
2
2013
1809
0.030
Why?
Serratia
1
2010
7
0.030
Why?
Syringes
1
2010
12
0.030
Why?
Young Adult
1
2018
2198
0.030
Why?
Blood Sedimentation
1
2010
65
0.030
Why?
Biopsy, Fine-Needle
1
2010
53
0.030
Why?
Interviews as Topic
1
2010
138
0.030
Why?
C-Reactive Protein
1
2010
132
0.030
Why?
Diagnostic Imaging
1
2010
95
0.030
Why?
Norfloxacin
1
1989
2
0.030
Why?
Drug Synergism
1
1989
68
0.030
Why?
Hip Joint
1
2013
323
0.020
Why?
Urinary Tract Infections
1
1989
32
0.020
Why?
Osteoarthritis, Knee
1
2013
355
0.020
Why?
Pneumonia
1
1989
75
0.020
Why?
Antigens, Bacterial
1
2006
7
0.020
Why?
Coxiella burnetii
1
2006
4
0.020
Why?
Australia
1
2006
43
0.020
Why?
Knee Joint
1
2013
721
0.020
Why?
Drug Implants
1
2005
14
0.020
Why?
Severity of Illness Index
1
2011
1220
0.020
Why?
Osteomyelitis
1
2005
22
0.020
Why?
Dogs
1
2005
284
0.020
Why?
Radiography
1
2005
714
0.020
Why?
Injections, Intravenous
1
1997
61
0.010
Why?
Drug Therapy, Combination
1
1997
264
0.010
Why?
Kidney Transplantation
1
1995
143
0.010
Why?
Dysentery, Bacillary
1
1990
2
0.010
Why?
Campylobacter fetus
1
1990
4
0.010
Why?
Salmonella Infections
1
1990
3
0.010
Why?
Double-Blind Method
1
1990
541
0.010
Why?
Randomized Controlled Trials as Topic
1
1990
357
0.010
Why?
Segreti's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description